David Lansky
CEO
CEO
David Lansky, PhD, is the President and Chief Executive Officer of the Pacific Business Group on Health (PBGH) and directs its efforts to improve the affordability and availability of high quality health care. Since 2008, he has led the coalition of 50 large employers and health care purchasers representing ten million Americans, including CalPERS, Wells Fargo, Intel, Safeway, Walmart, and Boeing.
A nationally-recognized expert in accountability, quality measurement and health IT, Lansky has served as the purchaser representative to numerous health care policymaking programs, including the Congressional Budget Office, the HHS Learning and Action Network, and the Healthcare Transformation Task Force.
From 2004 to 2008, Lansky was Senior Director of the Health Program at the Markle Foundation (NY), and from 1995 to 2004, he led the Foundation for Accountability (FACCT), a public-private venture developing quality measures and web-based tools to help consumers and purchasers assess the value of health care services and providers.
Before establishing FACCT, Lansky was a senior policy analyst for the Jackson Hole Group during the national health care reform debate of 1993-94. He led the Center for Outcomes Research and Education at the Providence Health System from 1988 to 1993.
He is the author of over 30 peer-reviewed papers on outcomes research and quality measurement and holds a PhD degree from the University of California, Berkeley.
From Singapore to England, every country that has more successfully managed health care costs than the U.S. has chosen a path of self-discipline and free-market restraints.
The U.S. spends more than any other country for health care. And economic ideals that should push costs down aren't actually working in our country's system.
Focusing on how to finance expanded coverage is often compared to moving the deck chairs around on the Titanic: the whole health care enterprise is sinking under the weight of its high costs, and no amount of shifting who pays how much will keep us all from going under.
As drug manufacturers launch a $100 million campaign in a bid to shift the blame over soaring drug prices, how might reporters best cover this urgent issue?
Amid talk of ACA repeal, the signs suggest that the new Congress and president will diminish the emphasis on value-based health care. Here's what reporters should keep in mind.
Rewarding physicians and hospitals for the value of care can dramatically improve care quality and lower costs. So why has the transition to this new model of care been so slow?
The goal of health care spending is to achieve good health results, and that requires measuring and rewarding success. Unfortunately, the measures likely to be used for the next stage of health reform won’t get us there.